PLRX - Pliant ends development of idiopathic pulmonary fibrosis asset bexotegrast June, 27 2025 04:32 PM Pliant Therapeutics Inc. 2025-06-27 16:32:50 ET More on Pliant Therapeutics Pliant Therapeutics: An Activist On Deck Pliant Therapeutics to trim about 45% of workforce Seeking Alpha’s Quant Rating on Pliant Therapeutics Historical earnings data for Pliant Therapeutics Financial information for Pliant Therapeutics For further details see: Pliant ends development of idiopathic pulmonary fibrosis asset bexotegrast